Traumatic brain injury and NADPH oxidase: A deep relationship

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Angeloni, Cristina ^a   Prata, Cecilia ^a   Vieceli Dalla Sega, Francesco ^a   Piperno, Roberto ^b   Hrelia, Silvana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Azienda USL di Bologna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; ENZYME INHIBITION; ENZYMES;

HARMFUL EFFECTS; MECHANICAL FORCE; MULTI-SUBUNIT ENZYMES; NEUROLOGICAL DISEASE; PATHOPHYSIOLOGY; PERMANENT DAMAGE; REACTIVE OXYGEN SPECIES; TRAUMATIC BRAIN INJURIES;

BRAIN;

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CYTOKINE;

BRAIN CORTEX; CELL DEATH; HIPPOCAMPUS; HUMAN; MICROGLIA; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; TRAUMATIC BRAIN INJURY; BRAIN; BRAIN INJURY; METABOLISM;

BRAIN; BRAIN INJURIES; CYTOKINES; HUMANS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84928394731     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/370312     Document Type: Review

References (130)

1. J. Leon-Carrion, M. D. R. Dominguez-Morales, J. M. Barroso y Martin, and F. Murillo-Cabezas, "Epidemiology of traumatic brain injury and subarachnoid hemorrhage," Pituitary, vol. 8, no. 3-4, pp. 197-202, 2005.
2. C. J. L. Murray and A. D. Lopez, "Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study," The Lancet, vol. 349, no. 9064, pp. 1498-1504, 1997.
3. A. A. Hyder, C. A. Wunderlich, P. Puvanachandra, G. Gururaj, and O. C. Kobusingye, "The impact of traumatic brain injuries: a global perspective," NeuroRehabilitation, vol. 22, no. 5, pp. 341-353, 2007.
4. F. Tagliaferri, C.compagnone, M. Korsic, F. Servadei, and J. Kraus, "A systematic review of brain injury epidemiology in Europe," Acta Neurochirurgica, vol. 148, no. 3, pp. 255-268, 2006.
5. J. H. Adams, D. I. Graham, and T. A. Gennarelli, "Head injury in man and experimental animals: neuropathology," Acta Neurochirurgica, Supplement, vol. 32, pp. 15-30, 1983.
6. K. E. Saatman, A.-C. Duhaime, R. Bullock et al. , "Classification of traumatic brain injury for targeted therapies," Journal of Neurotrauma, vol. 25, no. 7, pp. 719-738, 2008.
7. A. I. Maas, N. Stocchetti, and R. Bullock, "Moderate and severe traumatic brain injury in adults," The Lancet Neurology, vol. 7, no. 8, pp. 728-741, 2008.
8. J. J. Donkin and R. Vink, "Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments," Current Opinion in Neurology, vol. 23, no. 3, pp. 293-299, 2010.
9. E. Motori, J. Puyal, N. Toni et al. , "Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance," Cell Metabolism, vol. 18, no. 6, pp. 844-859, 2013.
10. S. Signoretti, A. Marmarou, B. Tavazzi et al. , "The protective effect of Cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury," Journal of Neurotrauma, vol. 21, no. 9, pp. 1154-1167, 2004.
11. A. Lewen, P. Matz, and P. H. Chan, "Free radical pathways in CNS injury," Journal of Neurotrauma, vol. 17,no. 10, pp. 871-890, 2000.
12. R. A. Floyd and J. M. Carney, "Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress," Annals of Neurology, vol. 32, pp. S22-S27, 1992.
13. A. J. Lambert and M. D. Brand, "Reactive oxygen species production by mitochondria," Methods in Molecular Biology, vol. 554, pp. 165-181, 2009.
14. M. A. Ansari, K. N. Roberts, and S. W. Scheff, "A time course of NADPH-oxidase up-regulation and endothelial nitric oxide synthase activation in the hippocampus following neurotrauma," Free Radical Biology and Medicine, vol. 77, pp. 21-29, 2014.
15. X.-Y. Lu,H.-D. Wang, J.-G. Xu, K. Ding, and T. Li, "NADPHoxidase inhibition improves neurological outcome in experimental traumatic brain injury," Neurochemistry International, vol. 69, no. 1, pp. 14-19, 2014.
16. I. N. Singh, P. G. Sullivan, Y. Deng, L. H. Mbye, and E. D. Hall, "Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy," Journal of Cerebral Blood Flow andMetabolism, vol. 26, no. 11, pp. 1407-1418, 2006.
17. S.-X. Song, J.-L. Gao, K.-J. Wang et al. , "Attenuation of brain edema and spatial learning deficits by the inhibition of NADPH oxidase activity using apocynin following diffuse traumatic brain injury in rats," Molecular Medicine Reports, vol. 7, no. 1, pp. 327-331, 2013.
18. Q. G. Zhang,M. D. Laird, D. Han et al. , "Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury," PLoS ONE, vol. 7, no. 4, Article ID e34504, 2012.
19. B. Y. Choi, B. G. Jang, J. H. Kim et al. , "Prevention of traumatic brain injury-induced neuronal death by inhibition of NADPH oxidase activation," Brain Research, vol. 1481, pp. 49-58, 2012.
20. C. L. Harrison and M. Dijkers, "Traumatic brain injury registries in the United States: an overview," Brain Injury, vol. 6, no. 3, pp. 203-212, 1992.
21. G. Teasdale and B. Jennett, "Assessment of coma and impaired consciousness. Apractical scale,"TheLancet, vol. 2, no. 7872, pp. 81-84, 1974.
22. B. Jennett, "Epidemiology of head injury," Journal of Neurology Neurosurgery and Psychiatry, vol. 60, no. 4, pp. 362-369, 1996.
23. J. T. Povlishock and D. I. Katz, "Update of neuropathology and neurological recovery after traumatic brain injury," Journal of Head Trauma Rehabilitation, vol. 20, no. 1, pp. 76-94, 2005.
24. T. A. Gennarelli, L. E. Thibault, J. H. Adams, D. I. Graham, C. J. Thompson, and R. P. Marcincin, "Diffuse axonal injury and traumatic coma in the primate," Annals of Neurology, vol. 12, no. 6, pp. 564-574, 1982.
25. J. M. Meythaler, J. D. Peduzzi, E. Eleftheriou, and T. A. Novack, "Current concepts: diffuse axonal injury-associated traumatic brain injury," Archives of Physical Medicine and Rehabilitation, vol. 82, no. 10, pp. 1461-1471, 2001.
26. T. Skandsen, K. A. Kvistad, O. Solheim, I. H. Strand, M. Folvik, and V. Anne, "Prevalence and impact of diffuse axonal injury in patients withmoderate and severe head injury: a cohort study of earlymagnetic resonance imaging findings and 1-year outcome: Clinical article," Journal of Neurosurgery, vol. 113, no. 3, pp. 556-563, 2010.
27. J. H. Adams, D. Doyle, I. Ford, T. A. Gennarelli, D. I. Graham, and D. R. McLellan, "Diffuse axonal injury in head injury: definition, diagnosis and grading," Histopathology, vol. 15, no. 1, pp. 49-59, 1989.
28. A. Buki and J. T. Povlishock, "All roads lead to disconnectionα-Traumatic axonal injury revisited," Acta Neurochirurgica, vol. 148, no. 2, pp. 181-193, 2006.
29. J. Y. Wang, K. Bakhadirov, H. Abdi et al. , "Longitudinal changes of structural connectivity in traumatic axonal injury," Neurology, vol. 77, no. 9, pp. 818-826, 2011.
30. C. B. Hutson, C. R. Lazo, F. Mortazavi, C. C. Giza, D. Hovda, and M. F. Chesselet, "Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat," Journal ofNeurotrauma, vol. 28, no. 9, pp. 1783-1801, 2011.
31. T. C. Lye and E. A. Shores, "Traumatic brain injury as a risk factor for Alzheimers disease: a review," Neuropsychology Review, vol. 10, no. 2, pp. 115-129, 2000.
32. A. C. McKee, R. C. Cantu, C. J. Nowinski et al. , "Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury," Journal of Neuropathology and Experimental Neurology, vol. 68, no. 7, pp. 709-735, 2009.
33. K. Beauchamp, H. Mutlak, W. R. Smith, E. Shohami, and P. F. Stahel, "Pharmacology of traumatic brain injury: where is the golden bullet?" Molecular Medicine, vol. 14, no. 11-12, pp. 731-740, 2008.
34. H. Bayir, V. E. Kagan, R. S. B. Clark et al. , "Neuronal NOSmediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury," Journal of Neurochemistry, vol. 101, no. 1, pp. 168-181, 2007.
35. E. D. Hall, M. R. Detloff, K. Johnson, and N. C. Kupina, "Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury," Journal of Neurotrauma, vol. 21, no. 1, pp. 9-20, 2004.
36. G. Lotocki, J. P. de Rivero Vaccari, E. R. Perez et al. , "Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia," Journal of Neurotrauma, vol. 26, no. 7, pp. 1123-1134, 2009.
37. P. B. L. Pun, J. Lu, and S. Moochhala, "Involvement of ROS in BBB dysfunction," Free Radical Research, vol. 43, no. 4, pp. 348-364, 2009.
38. H. Z. Toklu, T. Hakan, N. Biber, S. Solakoglu, A. V. Ogunc and G. Sener, "The protective effect of alpha lipoic acid against traumatic brain injury in rats," Free Radical Research, vol. 43,no. 7, pp. 658-667, 2009.
39. B. K. Siesjo, "Calcium-mediated processes in neuronal degeneration," Annals of the New York Academy of Sciences, vol. 747, pp. 140-161, 1994.
40. A. Biegon, P. A. Fry, C. M. Paden, A. Alexandrovich, J. Tsenter, and E. Shohami, "Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 5117-5122, 2004.
41. A. W. Unterberg, J. Stover, B. Kress, and K. L. Kiening, "Edema and brain trauma," Neuroscience, vol. 129, no. 4, pp. 1021-1029, 2004.
42. B. Liu and J. S. Hong, "Role of microglia in inflammationmediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention," Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 1, pp. 1-7, 2003.
43. E. Shohami, R. Bass, D. Wallach, A. Yamin, and R. Gallily, "Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury," Journal of Cerebral BloodFlowandMetabolism, vol. 16, no. 3, pp. 378-384, 1996.
44. M. A. Ansari, K. N. Roberts, and S. W. Scheff, "Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury," Free Radical Biology and Medicine, vol. 45, no. 4, pp. 443-452, 2008.
45. C. Shao, K. N. Roberts,W. R. Markesbery,S. W. Scheff, and M. A. Lovell, "Oxidative stress in head trauma in aging," Free Radical Biology and Medicine, vol. 41, no. 1, pp. 77-85, 2006.
46. M. Prins, T. Greco, D. Alexander, and C. C. Giza, "The pathophysiology of traumatic brain injury at a glance," Disease Models and Mechanisms, vol. 6, no. 6, pp. 1307-1315, 2013.
47. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, "Pathobiology of ischaemic stroke: an integrated view," Trends in Neurosciences, vol. 22, no. 9, pp. 391-397, 1999.
48. J. Sahuquillo, M. A. Poca, and S. Amoros, "Current aspects of pathophysiology and cell dysfunction after severe head injury," Current Pharmaceutical Design, vol. 7, no. 15, pp. 1475-1503, 2001.
49. T. I. Peng and M. J. Jou, "Oxidative stress caused by mitochondrial calcium overload," Annals of the New York Academy of Sciences, vol. 1201, pp. 183-188, 2010.
50. Y. Xiong, Q. Gu, P. L. Peterson, J. P. Muizelaar, and C. P. Lee, "Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury," Journal of Neurotrauma, vol. 14, no. 1, pp. 23-34, 1997.
51. F. Clausen, H. Lundqvist, S. Ekmark, A. Lewen, T. Ebendal, and L. Hillered, "Oxygen free radical-dependent activation of extracellular signal-regulated kinase mediates apoptosis-like cell death after traumatic brain injury," Journal of Neurotrauma, vol. 21, no. 9, pp. 1168-1182, 2004.
52. N. Marklund, F. Clausen, T. Lewander, and L. Hillered, "Monitoring of reactive oxygen species production after traumatic brain injury in rats with microdialysis and the 4-hydroxybenzoic acid trappingmethod," Journal of Neurotrauma, vol. 18, no. 11, pp. 1217-1227, 2001.
53. J. D. Lambeth and A. S. Neish, "Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited," Annual review of pathology, vol. 9, pp. 119-145, 2014.
54. N. Chaudhari, P. Talwar, A. Parimisetty, C. Lefebvre d'Hellencourt, and P. Ravanan, "A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress," Frontiers in Cellular Neuroscience, vol. 8, article 213, 2014.
55. B. Halliwell, "The role of oxygen radicals in human disease, with particular reference to the vascular system," Haemostasis, vol. 23, supplement 1, pp. 118-126, 1993.
56. H. L. Hsieh and C. M. Yang, "Role of redox signaling in neuroinflammation and neurodegenerative diseases," BioMed Research International, vol. 2013, Article ID 484613, 18 pages, 2013.
57. N. Kaludercic, S. Deshwal, and F. Di Lisa, "Reactive oxygen species and redox compartmentalization," Frontiers in Physiology, vol. 5, article 285, 2014.
58. S. I. Liochev, "Free radical paradoxes," Free Radical Biology and Medicine, vol. 65, pp. 232-233, 2013.
59. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, "Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options," Current Neuropharmacology, vol. 7, no. 1, pp. 65-74, 2009.
60. M. L. Circu and T. Y. Aw, "Reactive oxygen species, cellular redox systems, and apoptosis," Free Radical Biology and Medicine, vol. 48, no. 6, pp. 749-762, 2010.
61. P. S. Hole, R. L. Darley, and A. Tonks, "Do reactive oxygen species play a role in myeloid leukemias?" Blood, vol. 117, no. 22, pp. 5816-5826, 2011.
62. C. Cornelius, R. Crupi, V. Calabrese et al. , "Traumatic brain injury: oxidative stress and neuroprotection," Antioxidants and Redox Signaling, vol. 19, no. 8, pp. 836-853, 2013.
63. K. Keyer, A. S. Gort, and J. A. Imlay, "Superoxide and the production of oxidative DNA damage," Journal of Bacteriology, vol. 177, no. 23, pp. 6782-6790, 1995.
64. S. R. Thomas, P. K. Witting, and G. R. Drummond, "Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities," Antioxidants and Redox Signaling, vol. 10, no. 10, pp. 1713-1765, 2008.
65. T. Nishikawa, D. Edelstein, X. L. Du et al. , "Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage," Nature, vol. 404, no. 6779, pp. 787-790, 2000.
66. T. Maraldi, "Natural compounds as modulators of NADPH oxidases," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 271602, 10 pages, 2013.
67. F. Vieceli Dalla Sega, L. Zambonin, D. Fiorentini et al. , "Specific aquaporins facilitate Nox-produced hydrogen peroxide transport through plasma membrane in leukaemia cells," Biochimica et Biophysica Acta, vol. 1843, no. 4, pp. 806-814, 2014.
68. T. Finkel, "Signal transduction by reactive oxygen species," The Journal of Cell Biology, vol. 194, no. 1, pp. 7-15, 2011.
69. E. D. Hall and J. M. Braughler, "Free radicals in CNS injury," Research Publications-Association for Research in Nervous and Mental Disease, vol. 71, pp. 81-105, 1993.
70. M. M. Zaleska and R. A. Floyd, "Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron," Neurochemical Research, vol. 10, no. 3, pp. 397-410, 1985.
71. A. Rodriguez-Rodriguez, J. J. Egea-Guerrero, F. Murillo-Cabezas, and A. Carrillo-Vico, "Oxidative stress in traumatic brain injury," Current Medicinal Chemistry, vol. 21, no. 10, pp. 1201-1211, 2014.
72. A. Tarozzi, C. Angeloni,M. Malaguti, F. Morroni, S. Hrelia, and P. Hrelia, "Sulforaphane as a potential protective phytochemical against neurodegenerative diseases," Oxidative Medicine and Cellular Longevity, vol. 2013,Article ID 415078, 10 pages, 2013.
73. A. Minarini, A. Milelli, V. Tumiatti et al. , "Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimers disease treatment," Neuropharmacology, vol. 62, no. 2, pp. 997-1003, 2012.
74. Z.-G. Xiong, X.-M. Zhu, X.-P. Chu et al. , "Neuroprotection in ischemia: Blocking calcium-permeable acid-sensing ion channels," Cell, vol. 118, no. 6, pp. 687-698, 2004.
75. C. Ikonomidou and L. Turski, "Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?" The Lancet Neurology, vol. 1, no. 6, pp. 383-386, 2002.
76. J. Sastre, F. V. Pallardo, and J. Vina, "The role of mitochondrial oxidative stress in aging," Free Radical Biology and Medicine, vol. 35, no. 1, pp. 1-8, 2003.
77. H. A. Kontos and J. T. Povlishock, "Oxygen radicals in brain injury," Central Nervous System Trauma, vol. 3, no. 4, pp. 257-263, 1986.
78. H. A. Kontos and E. P. Wei, "Superoxide production in experimental brain injury," Journal of Neurosurgery, vol. 64, no. 5, pp. 803-807, 1986.
79. G. Barreto, R. E. White, Y. Ouyang, L. Xu, and R. G. Giffard, "Astrocytes: targets for neuroprotection in stroke," Central Nervous System Agents inMedicinal Chemistry, vol. 11, no. 2, pp. 164-173, 2011.
80. M. L. Block and J. S. Hong, "Microglia and inflammationmediated neurodegeneration: multiple triggers with a common mechanism," Progress in Neurobiology, vol. 76, no. 2, pp. 77-98, 2005.
81. J. M. C. Gutteridge, "Lipid peroxidation and antioxidants as biomarkers of tissue damage," Clinical Chemistry, vol. 41, no. 12, pp. 1819-1828, 1995.
82. A. G. Mustafa, I. N. Singh, J. Wang, K. M. Carrico, and E. D. Hall, "Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals," Journal of Neurochemistry, vol. 114, no. 1, pp. 271-280, 2010.
83. I. N. Singh, L. K. Gilmer, D. M. Miller, J. E. Cebak, J. A. Wang, and E. D. Hall, "Phenelzine mitochondrial functional preservation and neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4-hydroxy-2-nonenal," Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 4, pp. 593-599, 2013.
84. J. N. Keller, R. J. Mark, A. J. Bruce et al. , "4-hydroxynonenal, an aldehydic product ofmembrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes," Neuroscience, vol. 80, no. 3, pp. 685-696, 1997.
85. W. A. Pedersen, N. R. Cashman, and M. P. Mattson, "The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells," Experimental Neurology, vol. 155, no. 1, pp. 1-10, 1999.
86. R. Durmaz, G. Kanbak, F. Akyuz et al. , "Lazaroid attenuates edema by stabilizing ATPase in the traumatized rat brain," Canadian Journal ofNeurological Sciences, vol. 30,no. 2, pp. 143-149, 2003.
87. P. Racay, P. Kaplan, V. Mezesova, and J. Lehotsky, "Lipid peroxidation both inhibitsCa2+-ATPase and increasesCa2+ permeability of endoplasmic reticulum membrane," Biochemistry and Molecular Biology International, vol. 41, no. 4, pp. 647-655, 1997.
88. K. Wada, K. Chatzipanteli, S. Kraydieh, R. Busto, and W. D. Dietrich, "Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats," Neurosurgery, vol. 43, no. 6, pp. 1427-1436, 1998.
89. C. Mesenge, C. Charriaut-Marlangue, C. Verrecchia, M. Allix, R. R. Boulu, and M. Plotkine, "Reduction of tyrosine nitration after N'-nitro-l-arginine-methylester treatment of mice with traumatic brain injury," European Journal of Pharmacology, vol. 353, no. 1, pp. 53-57, 1998.
90. Y. Deng-Bryant, I. N. Singh, K. M. Carrico, and E. D. Hall, "Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse traumatic brain injury model," Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 6, pp. 1114-1126, 2008.
91. C. Gahm, S. Holmin, and T. Mathiesen, "Temporal profiles and cellular sources of three nitric oxide synthase isoforms in the brain after experimental contusion," Neurosurgery, vol. 46, no. 1, pp. 169-177, 2000.
92. C. S. Cobbs, A. Fenoy, D. S. Bredt, and L. J. Noble, "Expression of nitric oxide synthase in the cerebral microvasculature after traumatic brain injury in the rat," Brain Research, vol. 751, no. 2, pp. 336-338, 1997.
93. V. L. Raghavendra Rao, A. Dogan, K. K. Bowen, and R. J. Dempsey, "Traumatic injury to rat brain upregulates neuronal nitric oxide synthase expression and l-[3H]nitroarginine binding, " Journal of Neurotra ma, vol. 16, no. 10, pp. 865-877, 1999.
94. P. Ascenzi, A. Bocedi, P. Visca et al. , "Hemoglobin and heme scavenging," IUBMB Life, vol. 57, no. 11, pp. 749-759, 2005.
95. T. Arai, N. Takeyama, and T. Tanaka, "Glutathione monoethyl ester and inhibition of the oxyhemoglobin-induced increase in cytosolic calcium in cultured smooth-muscle cells," Journal of Neurosurgery, vol. 90, no. 3, pp. 527-532, 1999.
96. T. Asano, "Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions," Critical Reviews in Neurosurgery, vol. 9, no. 5, pp. 303-318, 1999.
97. F. Marzatico, P. Gaetani, C. Cafe, G. Spanu, and R. Rodriguez y Baena, "Antioxidant enzymatic activities after experimental subarachnoid hemorrhage in rats," Acta Neurologica Scandinavica, vol. 87, no. 1, pp. 62-66, 1993.
98. F. Marzatico, P. Gaetani, V. Silvani, D. Lombardi, E. Sinforiani, and R. Baena, "Experimental isobaric subarachnoid hemorrhage: regional mitochondrial function during the acute and late phase," Surgical Neurology, vol. 34, no. 5, pp. 294-300, 1990.
99. E. D. Hall, R. A. Vaishnav, and A. G. Mustafa, "Antioxidant therapies for traumatic brain injury," Neurotherapeutics, vol. 7, no. 1, pp. 51-61, 2010.
100. S. Rehncrona, H. N. Hauge, and B. K. Siesjo, "Enhancement of iron-catalyzed free radical formation by acidosis in brain homogenates: differences in effect by lactic acid and CO2," Journal of Cerebral Blood Flow andMetabolism, vol. 9, no. 1, pp. 65-70, 1989.
101. J. D. Lambeth and A. S. Neish, "Nox enzymes and newthinking on reactive oxygen: a double-edged sword revisited," Annual Review of Pathology, vol. 9, pp. 119-145, 2014.
102. A. Panday, M. K. Sahoo, D. Osorio, and S. Batra, "NADPH oxidases: an overview from structure to innate immunityassociated pathologies," Cellular and Molecular Immunology, vol. 12, no. 1, pp. 5-23, 2014.
103. H. Sumimoto, "Structure, regulation and evolution of Noxfamily NADPH oxidases that produce reactive oxygen species," FEBS Journal, vol. 275, no. 13, pp. 3249-3277, 2008.
104. K. Bedard and K.-H. Krause, "The NOX family of ROSgeneratingNADPHoxidases: physiology and pathophysiology," Physiological Reviews, vol. 87, no. 1, pp. 245-313, 2007.
105. S. Sorce and K. H. Krause, "NOXenzymes in the central nervous system: from signaling to disease," Antioxidants and Redox Signaling, vol. 11, no. 10, pp. 2481-2504, 2009.
106. A. Y. Abramov, J. Jacobson, F. Wientjes, J. Hothersall, L. Canevari, and M. R. Duchen, "Expression and modulation of an NADPH oxidase in mammalian astrocytes," The Journal of Neuroscience, vol. 25, no. 40, pp. 9176-9184, 2005.
107. S. H. Choi, Y. L. Da, U. K. Seung, and K. J. Byung, "Thrombininduced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase," The Journal of Neuroscience, vol. 25, no. 16, pp. 4082-4090, 2005.
108. A. P. O. Ferreira, F. S. Rodrigues, I. D. Della-Pace et al. , "The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: role of inflammatory and oxidative brain damage," Neurochemistry International, vol. 63, no. 6, pp. 583-593, 2013.
109. D. J. Loane, B. A. Stoica, K. R. Byrnes, W. Jeong, and A. I. Faden, "Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury," Journal of Neurotrauma, vol. 30,no. 5, pp. 403-412, 2013.
110. K. Dohi, H. Ohtaki, T. Nakamachi et al. , " Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury," Journal of Neuroinflammation, vol. 7, article 41, 2010.
111. J. Stolk, T. J. Hiltermann, J. H. Dijkman, and A. J. Verhoeven, "Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol," American Journal of Respiratory Cell andMolecular Biology, vol. 11, no. 1, pp. 95-102, 1994.
112. E. van den Worm, C. J. Beukelman, A. J. J. van den Berg, B. H. Kroes, R. P. Labadie, and H. van Dijk, "Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils," European Journal of Pharmacology, vol. 433, no. 2-3, pp. 225-230, 2001.
113. T. Hayashi, P. A. R. Juliet, H. Kano-Hayashi et al. , "NADPH oxidase inhibitor, apocynin, restores the impaired endothelialdependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction," Diabetes, Obesity andMetabolism, vol. 7, no. 4, pp. 334-343, 2005.
114. Y. Jinnouchi, S.-I. Yamagishi, T. Matsui et al. , "Administration of pigment epithelium-derived factor (PEDF) inhibits cold injuryinduced brain edema in mice," Brain Research, vol. 1167,no. 1, pp. 92-100, 2007.
115. D. J. Loane, A. Kumar, B. A. Stoica, R. Cabatbat, and A. I. Faden, "Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation," Journal of Neuropathology and Experimental Neurology, vol. 73, no. 1, pp. 14-29, 2014.
116. L. Qin, Y. Liu, J. S. Hong, and F. T. Crews, "NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration," Glia, vol. 61, no. 6, pp. 855-868, 2013.
117. M. E. Lull and M. L. Block, "Microglial activation and chronic neurodegeneration," Neurotherapeutics, vol. 7, no. 4, pp. 354-365, 2010.
118. A. Kumar, B. A. Stoica, B. Sabirzhanov, M. P. Burns, A. I. Faden, and D. J. Loane, "Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states," Neurobiology of Aging, vol. 34, no. 5, pp. 1397-1411, 2013.
119. S. J. Cooney, S. L. Bermudez-Sabogal, and K. R. Byrnes, "Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury," Journal of Neuroinflammation, vol. 10, article 155, 2013.
120. N. B. Chauhan, "Chronic neurodegenerative consequences of traumatic brain injury," RestorativeNeurology andNeuroscience, vol. 32, no. 2, pp. 337-365, 2014.
121. S. Shimohama, H. Tanino, N. Kawakami et al. , "Activation of NADPH oxidase in Alzheimers disease brains," Biochemical and Biophysical Research Communications, vol. 273, no. 1, pp. 5-9, 2000.
122. D. Zekry, T. Kay Epperson, and K.-H. Krause, "A role for NOX NADPH oxidases in Alzheimers disease and other types of dementia?" IUBMB Life, vol. 55, no. 6, pp. 307-313, 2003.
123. W. Zhang, T. Wang, L. Qin et al. , "Neuroprotective effect of dextromethorphan in theMPTP Parkinsons diseasemodel: role of NADPH oxidase," The FASEB journal, vol. 18, no. 3, pp. 589-591, 2004.
124. C. Angeloni, L. Zambonin, and S. Hrelia, "Role ofmethylglyoxal in alzheimers disease," BioMed Research International, vol. 2014, Article ID 238485, 12 pages, 2014.
125. H. M. Bramlett and W. D. Dietrich, "Pathophysiology of cerebral ischemia and brain trauma: similarities and differences," Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 2, pp. 133-150, 2004.
126. C. van den Heuvel, E. Thornton, and R. Vink, "Traumatic brain injury and Alzheimers disease: a review," Progress in Brain Research, vol. 161, pp. 303-316, 2007.
127. K. Beyer, M. Domingo-Sabat, and A. Ariza, "Molecular pathology of Lewy body diseases," International Journal of Molecular Sciences, vol. 10, no. 3, pp. 724-745, 2009.
128. T. Yasuda, Y. Nakata, and H. Mochizuki, "α-Synuclein and neuronal cell death," Molecular neurobiology, vol. 47, no. 2, pp. 466-483, 2013.
129. S. A. Acosta, N. Tajiri, I. de la Pena et al. , "Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinsons disease," Journal of Cellular Physiology, vol. 230, no. 5, pp. 1024-1032, 2015.
130. A. C. Cristovao, S. Guhathakurta, E. Bok et al. , "Nadph oxidase 1 mediates alpha-synucleinopathy in Parkinsons disease," The Journal of Neuroscience, vol. 32, no. 42, pp. 14465-14477, 2012.